UBS’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$208M Sell
2,942,077
-199,235
-6% -$14.2M 0.15% 147
2014
Q2
$218M Sell
3,141,312
-28,524
-0.9% -$2.01M 0.17% 140
2014
Q1
$238M Buy
3,169,836
+346,320
+12% +$25.9M 0.21% 105
2013
Q4
$198M Buy
2,823,516
+223,636
+9% +$14.6M 0.19% 122
2013
Q3
$161M Buy
2,599,880
+339,347
+15% +$21.9M 0.16% 138
2013
Q2
$140M Buy
+2,260,533
New +$136M 0.17% 133

Other funds holding ESRX

UBS's ESRX Position: Q3 2014 in Review

UBS reduced its Express Scripts Holding Company (ESRX) stake by 6.3% in Q3 2014, selling an estimated $14.2M and leaving 2,942,077 shares worth $208M. The position accounts for 0.15% of the portfolio, ranked #147.

UBS first reported a position in ESRX in Q2 2013 and has held it in 6 quarters since. The position peaked at $238M in Q1 2014. 1,121 funds tracked by Wall St. Rank hold ESRX as of Q3 2014.

  • UBS held 2,942,077 shares of Express Scripts Holding Company worth $208M as of Q3 2014.
  • UBS sold 199,235 Express Scripts Holding Company shares in Q3 2014, an estimated $14.2M.
  • Express Scripts Holding Company made up 0.15% of UBS's portfolio in Q3 2014, its #147 holding.
  • UBS first reported a position in Express Scripts Holding Company in Q2 2013 and has held it in 6 quarters since.
  • UBS's Express Scripts Holding Company position peaked at $238M in Q1 2014.
  • 1,121 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.